Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 156 entries
Sorted by: Best Match Show Resources per page
A competitive system: Graduate student recruitment in STEM and why money may not be the answer

Theoretical frames STEM

Knight DB, Lyles CH.
GSID: er007Vy27WgJ
WE Wall Bortz, DB Knight, CH Lyles… - The Journal of Higher …, 2020 - Taylor & Francis

… This theoretical framing was particularly useful for investigating our research questions … demonstrate that recruitment strategies within STEM doctoral programs (ie, the theory-in-use) …

Cite
Wall Bortz, W. E., Knight, D. B., Lyles, C. H., Kinoshita, T., Choe, N. H., Denton, M., & Borrego, M. (2020). A competitive system: Graduate student recruitment in STEM and why money may not be the answer. The Journal of Higher Education, 91(6), 927-952.
Wall Bortz, Whitney E., et al. "A competitive system: Graduate student recruitment in STEM and why money may not be the answer." The Journal of Higher Education 91.6 (2020): 927-952.
Copy Download .nbib Format: MLA
Selecting and improving quasi-experimental designs in effectiveness and implementation research

quasi-experimental designs

Handley MA, Lyles CR.
GSID: P7W9dBzwlzMJ
MA Handley, CR Lyles, C McCulloch… - Annual review of …, 2018 - annualreviews.org

… Quasi-experimental designs (QEDs) are increasingly employed to achieve a balance between internal and external validity. Although these designs are … We focus here on commonly used QEDs (prepost designs with nonequivalent control groups, interrupted time series, and …

Cite
Handley, M. A., Lyles, C. R., McCulloch, C., & Cattamanchi, A. (2018). Selecting and improving quasi-experimental designs in effectiveness and implementation research. Annual review of public health, 39, 5-25.
Handley, Margaret A., et al. "Selecting and improving quasi-experimental designs in effectiveness and implementation research." Annual review of public health 39 (2018): 5-25.
Copy Download .nbib Format: MLA
Inadequate collaboration: A challenge to reaching global targets for non-communicable disease control and prevention.

Journal of public health policy

Christiani Y, Tavener M, Byles JE, Dugdale P.
PMID: 26675147
J Public Health Policy. 2016 Feb;37(1):114-7. doi: 10.1057/jphp.2015.44. Epub 2015 Dec 17.

No abstract available.

Cite
Christiani Y, Tavener M, Byles JE, et al. Inadequate collaboration: A challenge to reaching global targets for non-communicable disease control and prevention. J Public Health Policy. 2015;37(1):114-7doi: 10.1057/jphp.2015.44.
Christiani, Y., Tavener, M., Byles, J. E., & Dugdale, P. (2016). Inadequate collaboration: A challenge to reaching global targets for non-communicable disease control and prevention. Journal of public health policy, 37(1), 114-7. https://doi.org/10.1057/jphp.2015.44
Christiani, Yodi, et al. "Inadequate collaboration: A challenge to reaching global targets for non-communicable disease control and prevention." Journal of public health policy vol. 37,1 (2016): 114-7. doi: https://doi.org/10.1057/jphp.2015.44
Christiani Y, Tavener M, Byles JE, Dugdale P. Inadequate collaboration: A challenge to reaching global targets for non-communicable disease control and prevention. J Public Health Policy. 2016 Feb;37(1):114-7. doi: 10.1057/jphp.2015.44. Epub 2015 Dec 17. PMID: 26675147.
Copy Download .nbib Format: NLM
A separation of protactinium from neutron-irradiated thorium.

Talanta

Lyle SJ, Shendrikar AD.
PMID: 18959855
Talanta. 1966 Jan;13(1):140-2. doi: 10.1016/0039-9140(66)80137-6.

A convenient-method, based on liquid-liquid extraction with N-benzoyl-N-phenylhydroxylamine in chloroform, is given for the separation of protactinium-233 from neutron-irradiated thorium.

Cite
Lyle SJ, Shendrikar AD. A separation of protactinium from neutron-irradiated thorium. Talanta. 1966;13(1):140-2doi: 10.1016/0039-9140(66)80137-6.
Lyle, S. J., & Shendrikar, A. D. (1966). A separation of protactinium from neutron-irradiated thorium. Talanta, 13(1), 140-2. https://doi.org/10.1016/0039-9140(66)80137-6
Lyle, S J, and Shendrikar, A D. "A separation of protactinium from neutron-irradiated thorium." Talanta vol. 13,1 (1966): 140-2. doi: https://doi.org/10.1016/0039-9140(66)80137-6
Lyle SJ, Shendrikar AD. A separation of protactinium from neutron-irradiated thorium. Talanta. 1966 Jan;13(1):140-2. doi: 10.1016/0039-9140(66)80137-6. PMID: 18959855.
Copy Download .nbib Format: NLM
Spectrophotometric determination of iron and cobalt with Ferrozine and dithizone.

Talanta

Dawson MV, Lyle SJ.
PMID: 18965094
Talanta. 1990 Dec;37(12):1189-91. doi: 10.1016/0039-9140(90)80191-h.

Procedures are described whereby iron (1-50 microg) and cobalt (1-25 microg) are determined spectrophotometrically, iron as iron(II) with the disodium salt of 3-(2-pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-triazine (Ferrozine) and cobalt as the cobalt(III) dithizonate complex. The reduction to iron(II) prevents interference of...

Cite
Dawson MV, Lyle SJ. Spectrophotometric determination of iron and cobalt with Ferrozine and dithizone. Talanta. 1990;37(12):1189-91doi: 10.1016/0039-9140(90)80191-h.
Dawson, M. V., & Lyle, S. J. (1990). Spectrophotometric determination of iron and cobalt with Ferrozine and dithizone. Talanta, 37(12), 1189-91. https://doi.org/10.1016/0039-9140(90)80191-h
Dawson, M V, and Lyle, S J. "Spectrophotometric determination of iron and cobalt with Ferrozine and dithizone." Talanta vol. 37,12 (1990): 1189-91. doi: https://doi.org/10.1016/0039-9140(90)80191-h
Dawson MV, Lyle SJ. Spectrophotometric determination of iron and cobalt with Ferrozine and dithizone. Talanta. 1990 Dec;37(12):1189-91. doi: 10.1016/0039-9140(90)80191-h. PMID: 18965094.
Copy Download .nbib Format: NLM
Equity of access to cardiac rehabilitation: the role of system factors.

International journal for equity in health

Williams JA, Byles JE, Inder KJ.
PMID: 20205776
Int J Equity Health. 2010 Jan 21;9:2. doi: 10.1186/1475-9276-9-2.

BACKGROUND: When patient selection processes determine who can and cannot use healthcare there can be inequalities and inequities in individuals' opportunities to benefit. This paper evaluates the influence of a hospital selection process on opportunities to access outpatient cardiac...

Cite
Williams JA, Byles JE, Inder KJ. Equity of access to cardiac rehabilitation: the role of system factors. Int J Equity Health. 2010;9:2doi: 10.1186/1475-9276-9-2.
Williams, J. A., Byles, J. E., & Inder, K. J. (2010). Equity of access to cardiac rehabilitation: the role of system factors. International journal for equity in health, 92. https://doi.org/10.1186/1475-9276-9-2
Williams, Jennifer A Stewart, et al. "Equity of access to cardiac rehabilitation: the role of system factors." International journal for equity in health vol. 9 (2010): 2. doi: https://doi.org/10.1186/1475-9276-9-2
Williams JA, Byles JE, Inder KJ. Equity of access to cardiac rehabilitation: the role of system factors. Int J Equity Health. 2010 Jan 21;9:2. doi: 10.1186/1475-9276-9-2. PMID: 20205776; PMCID: PMC2823593.
Copy Download .nbib Format: NLM
Interferon response and viral evasion by members of the family rhabdoviridae.

Viruses

Faul EJ, Lyles DS, Schnell MJ.
PMID: 21994572
Viruses. 2009 Dec;1(3):832-51. doi: 10.3390/v1030832. Epub 2009 Nov 09.

Like many animal viruses, those of the Rhabdoviridae family, are able to antagonize the type I interferon response and cause disease in mammalian hosts. Though these negative-stranded RNA viruses are very simple and code for as few as five...

Cite
Faul EJ, Lyles DS, Schnell MJ. Interferon response and viral evasion by members of the family rhabdoviridae. Viruses. 2009;1(3):832-51doi: 10.3390/v1030832.
Faul, E. J., Lyles, D. S., & Schnell, M. J. (2009). Interferon response and viral evasion by members of the family rhabdoviridae. Viruses, 1(3), 832-51. https://doi.org/10.3390/v1030832
Faul, Elizabeth J, et al. "Interferon response and viral evasion by members of the family rhabdoviridae." Viruses vol. 1,3 (2009): 832-51. doi: https://doi.org/10.3390/v1030832
Faul EJ, Lyles DS, Schnell MJ. Interferon response and viral evasion by members of the family rhabdoviridae. Viruses. 2009 Dec;1(3):832-51. doi: 10.3390/v1030832. Epub 2009 Nov 09. PMID: 21994572; PMCID: PMC3185512.
Copy Download .nbib Format: NLM
Evaluation of a Health Information Technology-Enabled Collective Intelligence Platform to Improve Diagnosis in Primary Care and Urgent Care Settings: Protocol for a Pragmatic Randomized Controlled Trial.

JMIR research protocols

Fontil V, Khoong EC, Hoskote M, Radcliffe K, Ratanawongsa N, Lyles CR, Sarkar U.
PMID: 31389337
JMIR Res Protoc. 2019 Aug 06;8(8):e13151. doi: 10.2196/13151.

BACKGROUND: Diagnostic error in ambulatory care, a frequent cause of preventable harm, may be mitigated using the collective intelligence of multiple clinicians. The National Academy of Medicine has identified enhanced clinician collaboration and digital tools as a means to...

Cite
Fontil V, Khoong EC, Hoskote M, et al. Evaluation of a Health Information Technology-Enabled Collective Intelligence Platform to Improve Diagnosis in Primary Care and Urgent Care Settings: Protocol for a Pragmatic Randomized Controlled Trial. JMIR Res Protoc. 2019;8(8):e13151doi: 10.2196/13151.
Fontil, V., Khoong, E. C., Hoskote, M., Radcliffe, K., Ratanawongsa, N., Lyles, C. R., & Sarkar, U. (2019). Evaluation of a Health Information Technology-Enabled Collective Intelligence Platform to Improve Diagnosis in Primary Care and Urgent Care Settings: Protocol for a Pragmatic Randomized Controlled Trial. JMIR research protocols, 8(8), e13151. https://doi.org/10.2196/13151
Fontil, Valy, et al. "Evaluation of a Health Information Technology-Enabled Collective Intelligence Platform to Improve Diagnosis in Primary Care and Urgent Care Settings: Protocol for a Pragmatic Randomized Controlled Trial." JMIR research protocols vol. 8,8 (2019): e13151. doi: https://doi.org/10.2196/13151
Fontil V, Khoong EC, Hoskote M, Radcliffe K, Ratanawongsa N, Lyles CR, Sarkar U. Evaluation of a Health Information Technology-Enabled Collective Intelligence Platform to Improve Diagnosis in Primary Care and Urgent Care Settings: Protocol for a Pragmatic Randomized Controlled Trial. JMIR Res Protoc. 2019 Aug 06;8(8):e13151. doi: 10.2196/13151. PMID: 31389337; PMCID: PMC6701158.
Copy Download .nbib Format: NLM
Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin.

Vaccines

Westcott MM, Smedberg J, Jorgensen MJ, Puckett S, Lyles DS.
PMID: 29562688
Vaccines (Basel). 2018 Mar 19;6(1). doi: 10.3390/vaccines6010016.

Recombinant vesicular stomatitis virus (VSV) is a promising platform for vaccine development. M51R VSV, an attenuated, M protein mutant strain, is an effective inducer of Type I interferon and dendritic cell (DC) maturation, which are desirable properties to exploit...

Cite
Westcott MM, Smedberg J, Jorgensen MJ, et al. Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin. Vaccines (Basel). 2018;6(1)doi: 10.3390/vaccines6010016.
Westcott, M. M., Smedberg, J., Jorgensen, M. J., Puckett, S., & Lyles, D. S. (2018). Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin. Vaccines, 6(1), . https://doi.org/10.3390/vaccines6010016
Westcott, Marlena M, et al. "Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin." Vaccines vol. 6,1 (2018). doi: https://doi.org/10.3390/vaccines6010016
Westcott MM, Smedberg J, Jorgensen MJ, Puckett S, Lyles DS. Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin. Vaccines (Basel). 2018 Mar 19;6(1). doi: 10.3390/vaccines6010016. PMID: 29562688; PMCID: PMC5874657.
Copy Download .nbib Format: NLM
Safety-net institutions in the US grapple with new cholesterol treatment guidelines: a qualitative analysis from the PHoENIX Network.

Risk management and healthcare policy

Fontil V, Lyles CR, Schillinger D, Handley MA, Ackerman S, Gourley G, Bibbins-Domingo K, Sarkar U.
PMID: 30034258
Risk Manag Healthc Policy. 2018 Jul 12;11:99-108. doi: 10.2147/RMHP.S156311. eCollection 2018.

BACKGROUND: Clinical performance measures, such as for cholesterol control targets, have played an integral role in assessing the value of care and translating evidence into clinical practice. New guidelines often require development of corresponding performance metrics and systems changes...

Cite
Fontil V, Lyles CR, Schillinger D, et al. Safety-net institutions in the US grapple with new cholesterol treatment guidelines: a qualitative analysis from the PHoENIX Network. Risk Manag Healthc Policy. 2018;11:99-108doi: 10.2147/RMHP.S156311.
Fontil, V., Lyles, C. R., Schillinger, D., Handley, M. A., Ackerman, S., Gourley, G., Bibbins-Domingo, K., & Sarkar, U. (2018). Safety-net institutions in the US grapple with new cholesterol treatment guidelines: a qualitative analysis from the PHoENIX Network. Risk management and healthcare policy, 1199-108. https://doi.org/10.2147/RMHP.S156311
Fontil, Valy, et al. "Safety-net institutions in the US grapple with new cholesterol treatment guidelines: a qualitative analysis from the PHoENIX Network." Risk management and healthcare policy vol. 11 (2018): 99-108. doi: https://doi.org/10.2147/RMHP.S156311
Fontil V, Lyles CR, Schillinger D, Handley MA, Ackerman S, Gourley G, Bibbins-Domingo K, Sarkar U. Safety-net institutions in the US grapple with new cholesterol treatment guidelines: a qualitative analysis from the PHoENIX Network. Risk Manag Healthc Policy. 2018 Jul 12;11:99-108. doi: 10.2147/RMHP.S156311. eCollection 2018. PMID: 30034258; PMCID: PMC6047605.
Copy Download .nbib Format: NLM
Identification of Ellagic Acid Rhamnoside as a Bioactive Component of a Complex Botanical Extract with Anti-biofilm Activity.

Frontiers in microbiology

Fontaine BM, Nelson K, Lyles JT, Jariwala PB, García-Rodriguez JM, Quave CL, Weinert EE.
PMID: 28386254
Front Microbiol. 2017 Mar 23;8:496. doi: 10.3389/fmicb.2017.00496. eCollection 2017.

No abstract available.

Cite
Fontaine BM, Nelson K, Lyles JT, et al. Identification of Ellagic Acid Rhamnoside as a Bioactive Component of a Complex Botanical Extract with Anti-biofilm Activity. Front Microbiol. 2017;8:496doi: 10.3389/fmicb.2017.00496.
Fontaine, B. M., Nelson, K., Lyles, J. T., Jariwala, P. B., García-Rodriguez, J. M., Quave, C. L., & Weinert, E. E. (2017). Identification of Ellagic Acid Rhamnoside as a Bioactive Component of a Complex Botanical Extract with Anti-biofilm Activity. Frontiers in microbiology, 8496. https://doi.org/10.3389/fmicb.2017.00496
Fontaine, Benjamin M, et al. "Identification of Ellagic Acid Rhamnoside as a Bioactive Component of a Complex Botanical Extract with Anti-biofilm Activity." Frontiers in microbiology vol. 8 (2017): 496. doi: https://doi.org/10.3389/fmicb.2017.00496
Fontaine BM, Nelson K, Lyles JT, Jariwala PB, García-Rodriguez JM, Quave CL, Weinert EE. Identification of Ellagic Acid Rhamnoside as a Bioactive Component of a Complex Botanical Extract with Anti-biofilm Activity. Front Microbiol. 2017 Mar 23;8:496. doi: 10.3389/fmicb.2017.00496. eCollection 2017. PMID: 28386254; PMCID: PMC5362615.
Copy Download .nbib Format: NLM
Correction: Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance.

PloS one

Quave CL, Lyles JT, Kavanaugh JS, Nelson K, Parlet CP, Crosby HA, Heilmann KP, Horswill AR.
PMID: 27657727
PLoS One. 2016 Sep 22;11(9):e0163655. doi: 10.1371/journal.pone.0163655. eCollection 2016.

[This corrects the article DOI: 10.1371/journal.pone.0136486.].

Cite
Quave CL, Lyles JT, Kavanaugh JS, et al. Correction: Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance. PLoS One. 2016;11(9):e0163655doi: 10.1371/journal.pone.0163655.
Quave, C. L., Lyles, J. T., Kavanaugh, J. S., Nelson, K., Parlet, C. P., Crosby, H. A., Heilmann, K. P., & Horswill, A. R. (2016). Correction: Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance. PloS one, 11(9), e0163655. https://doi.org/10.1371/journal.pone.0163655
Quave, C L, et al. "Correction: Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance." PloS one vol. 11,9 (2016): e0163655. doi: https://doi.org/10.1371/journal.pone.0163655
Quave CL, Lyles JT, Kavanaugh JS, Nelson K, Parlet CP, Crosby HA, Heilmann KP, Horswill AR. Correction: Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance. PLoS One. 2016 Sep 22;11(9):e0163655. doi: 10.1371/journal.pone.0163655. eCollection 2016. PMID: 27657727; PMCID: PMC5033592.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 156 entries